Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXU0IR
|
||||
Drug Name |
(S)-4-((5-((4-(1-naphthoyl)-2-butylpiperazin-1-yl)methyl)-1H-imidazol-1-yl)methyl)benzonitrile
|
||||
Synonyms |
CHEMBL331496
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C31H33N5O
|
||||
Canonical SMILES |
CCCC[C@H]1CN(CCN1Cc2cncn2Cc3ccc(cc3)C#N)C(=O)c4cccc5ccccc45
|
||||
InChI |
InChI=1S/C31H33N5O/c1-2-3-9-27-21-35(31(37)30-11-6-8-26-7-4-5-10-29(26)30)17-16-34(27)22-28-19-33-23-36(28)20-25-14-12-24(18-32)13-15-25/h4-8,10-15,19,23,27H,2-3,9,16-17,20-22H2,1H3/t27-/m0/s1
|
||||
InChIKey |
QVELSCNTBHCXNR-MHZLTWQESA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.